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Synapse abnormalities in Huntington’s disease (HD) patients can precede clinical diagnosis and neuron loss
by decades. The polyglutamine expansion in the huntingtin (htt) protein that underlies this disorder leads to
perturbations in many cellular pathways, including the disruption of Rab11-dependent endosomal recycling.
Impairment of the small GTPase Rab11 leads to the defective formation of vesicles in HD models and may
thus contribute to the early stages of the synaptic dysfunction in this disorder. Here, we employ transgenic
Drosophila melanogaster models of HD to investigate anomalies at the synapse and the role of Rab11 in this
pathology. We ﬁnd that the expression of mutant htt in the larval neuromuscular junction decreases the pre-
synaptic vesicle size, reduces quantal amplitudes and evoked synaptic transmission and alters larval crawl-
ing behaviour. Furthermore, these indicators of early synaptic dysfunction are reversed by the
overexpression of Rab11. This work highlights a potential novel HD therapeutic strategy for early interven-
tion, prior to neuronal loss and clinical manifestation of disease.
INTRODUCTION
Neurodegenerative disorders such as Huntington’s disease
(HD), Alzheimer’s disease and Parkinson’s disease are devas-
tating fatal conditions characterized by the death of speciﬁc
populations of neurons. HD is an autosomal dominant disorder
causedbytheexpansionofapolyglutaminetractinthehunting-
tin(htt)protein(1).Lossofmediumspinyneuronsinthestriatal
region of the brain is associated with many of the characteristic
locomotor and cognitive deﬁcits of HD (2). The underlying
mechanisms contributing to this neuronal loss have been exten-
sively explored and appear tobe due toa myriad of cellular per-
turbations (3). These events may be critical for HD
pathogenesis, but the neuronal and synaptic dysfunction
occurs decades before the clinical onset ofdiseaseand probably
contributes to early cognitive changes in patients (4–6).
Bothclinicalandmousestudiessuggestthatthesynapticdys-
function in HD comprises several related anomalies at the
synapse, including, but not limited to, dendritic spine loss,
reduced synaptic connectivity, glutamatergic signal transduc-
tion and presynaptic reduction of brain-derived neurotrophic
factor (7). These changes may not only contribute to early ab-
normalities, but could also sensitize the relevant neurons to
other pathological stresses, as well as normal aging processes.
Importantly, the mechanistic dissection of synaptic disorder
has therapeutic relevance, since synapses have the capacity
forplasticity,growthandexpansion,whereasthelossofneuron-
al cell bodies is difﬁcult to reverse (8).
Recent studies have shown that the small Rab-family
GTPase Rab11, which plays a key role in endosomal recycling
(9–11), is functionally perturbed in several models of HD
(12–15). Indeed, the inhibition of Rab11 activity by mutant
htt impairs vesicle formation from recycling endosomes in
HD patient ﬁbroblasts (13). We recently found that Rab11
abrogated the loss of dendritic spines in primary murine
neurons expressing mutant htt, suggesting that Rab11 may
†Authors made equal contributions.
∗To whom correspondence should be addressed. Tel: +44 1162523485; Fax: +44 1162523378; Email: fg36@le.ac.uk
# The Author 2012. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop-
erly cited.
Human Molecular Genetics, 2012, Vol. 21, No. 13 2912–2922
doi:10.1093/hmg/dds117
Advance Access published on March 30, 2012Human Molecular Genetics, 2012, Vol. 21, No. 13 2913play a critical early role in the synaptic dysfunction observed
in HD (15). Furthermore, Rab11 overexpression reduced neu-
rodegeneration in a fruit ﬂy model of HD and also extended
lifespan and ameliorated defective emergence of the adult
ﬂy from the pupal case (15).
Here, we consolidate and extend these observations by ex-
ploring the role of Rab11 in the synaptic dysfunction at the
Drosophila larva neuromuscular junction (NMJ), a well-
established model of glutamatergic synaptic transmission
(16). The larval NMJ is organized into presynaptic boutons
rich in synaptic vesicles (SVs), active zones and a subsynaptic
reticulum with the dense expression of glutamate receptors.
Employing a multipronged approach, we ﬁnd that mutant htt
reduces the miniature excitatory junction potential (mEJP)
amplitudes produced by the release of individual SVs (i.e.
quantal size) at the NMJ and that this is likely due to
smaller SV volume, subsequently leading to a reduction in
evoked EJP (eEJP) amplitudes. Furthermore, we ﬁnd that the
restoration of SV size via Rab11 overexpression is sufﬁcient
to completely rescue quantal size. Finally, behavioural
defects observed in larvae expressing mutant htt can also be
abrogated by Rab11 overexpression. These results demon-
strate that Rab11 plays an important role in the early synaptic
dysfunction caused by mutant htt and that interventions target-
ing Rab11 function prior to the clinical manifestation of
disease may have therapeutic relevance for HD.
RESULTS
Mutant htt-expressing larval NMJs show a reduced
quantal size and evoked release
The fruit ﬂy Drosophila melanogaster has been extensively
exploited for the study of HD and other polyglutamine disor-
ders (17). A robust and widely used model of HD has been
generated using the UAS/Gal4 bipartite expression system to
drive the pan-neuronal expression of a human exon 1 fragment
of mutant htt (Htt93Q) with the elav-GAL4 driver (18). These
ﬂies present several disease-relevant phenotypes, including
neurodegeneration, shortened lifespan and locomotor deﬁcits.
An alternate model expressing full-length mutant htt has
also been developed (Htt128Q
FL), which though less severe
than the Htt93Q ﬂies, also exhibits several phenotypes remin-
iscent of disease pathology (19).
In order to investigate early events in presynaptic dysfunc-
tion, we studied synaptic transmission at the NMJ of third
instar larvae with the pan-neuronal expression of either
Htt93Q or Htt128Q
FL under physiological conditions in a
haemolymph-like buffer with 1.5 mM Ca
2+ (HL-3). A previous
study found a potentiation of transmitter release in Htt128Q
FL
larvae in lower HL-3 Ca
2+ concentrations (a modest increase
at 0.6 mM and a dramatic  5-fold increase at 0.25 mM)( 19).
We thus also repeated recordings in lowered Ca
2+ (0.6 mM)
and found identical eEJP amplitude values in Htt128Q
FL
larvae as Romero et al. (19) (Fig. 1A and B). However,
these values represented a reduction in eEJP amplitudes in
both Htt93Q and Htt128Q
FL larvae compared with their corre-
sponding UAS controls when recorded at either 0.6 or 1.5 mM
Ca
2+ concentration. Larvae expressing a control Htt20Q exon
1 fragment did not show different eEJP amplitudes at either
Ca
2+ concentration [Fig. 1A and B, three-way analysis of vari-
ance (ANOVA), htt background F2,52 ¼ 16.6, P , 0.0001;
transgene expression F1,52 ¼ 19.05, P , 0.0001, Ca
2+ con-
centration F1,52 ¼ 50.7, P   0 and htt background × transgene
expression interaction F2,52 ¼ 10.1, P , 0.0002]. Further-
more, we did not observe signiﬁcantly altered eEJP amplitudes
in larvae with the elav-driven expression of a full-length htt
control(Htt16Q
FL)orGal4aloneatphysiologicalCa
2+concen-
trations (Supplementary Material, Fig. S1). The background ×
transgeneinteractionisreﬂectedinthesigniﬁcantpost-hocpair-
wise differences between the expressed and the control geno-
types among the different htt backgrounds (Fig. 1B). In order
to compare uncorrected eEJP amplitudes, we observed that
resting membrane potentials were similar between conditions
at both Ca
2+ doses (shown for 1.5 mM Ca
2+ in Figure 1C, three-
way ANOVA, no signiﬁcant F-ratios), with mean potentials
ranging between 267+3 and 275+5 mV. Thus, the
effects of non-linear summation are likely to be small and amp-
litude correction was unnecessary.
Changes in eEJP amplitudes can be caused by altered quantal
size (20,21), changes in release probability (22,23) or glutamate
receptor composition/expression (24). In order to identify the
underlying mechanisms for the observed eEJP amplitude
changes in mutant htt-expressing larval NMJs, we analysed
mEJPs in all three htt-expressing lines. As shown in Figure 1D,
average relative cumulative frequency histograms and histo-
gramsformEJPamplitudesdemonstratedanincreasedprobabil-
ity of small amplitude events and hence a left shift in mEJP
amplitude distributions in Htt93Q [Kolmogorov–Smirnov
(K-S) test, D ¼ 0.38, P , 0.0001] and Htt128Q
FL larvae (D ¼
0.54, P , 0.0001) compared with UAS controls, and no
change in Htt20Q expressing larvae (D ¼ 0.087, P ¼ 0.88).
Htt16Q
FL and Gal4 control larvae exhibited no change in
mEJP amplitudes at physiological Ca
2+ concentrations (Supple-
mentary Material, Fig. S1). These data strongly indicate that
mutant htt-mediated eEJP alterations are due to a reduced
quantal amplitude or glutamate receptor dynamics.
The predominant Drosophila postsynaptic glutamate recep-
tors are DGluRIIa and DGluRIIb, each of which has distinct
decay kinetics (24) and which both compete for access to
Figure 1. Mutant htt expression causes a reduction in evoked transmission and quantal size. (A) Evoked (eEJP) recordings from Drosophila larvae NMJs expres-
sing Htt93Q, Htt128Q
FL or Htt20Q constructs recorded in HL-3. Note, arrows indicate ﬁrst threshold and compound peaks. (B) eEJP amplitudes are reduced in
larvae expressing Htt93Q and Htt128Q
FL at both 1.5 mM (black) and 0.6 mM (red) extracellular Ca
2+ (mean+SEM with n indicated within each bar). Compar-
isons are between htt transgene expressing (+) and UAS control (2) larvae. Expression of Htt20Q has no effect on eEJPs. (C) Mean resting membrane potentials
are similar between genotypes. (D) Top, sample mEJP recordings for the genotypes indicated. Middle, relative cumulative frequency histograms for the mEJP
amplitudes (Htt93Q and Htt128Q
FL have different distributions versus controls, K-S test: P , 0.0001 in both cases, Htt20Q was not different from control).
Bottom, mEJP amplitude histograms indicate the left shift of mEJPs in Htt93Q and Htt128Q
FL but not in Htt20Q. (E) Top, relative cumulative frequency histo-
grams for the mEJP decay kinetics (Htt93Q, Htt128Q
FL and Htt20Q do not show signiﬁcantly different distributions, K-S test: P . 0.05 in all cases). Bottom,
mEJP decay kinetics histograms in Htt93Q, Htt128Q
FL and Htt20Q. (F) Summary graphs for mEJP amplitudes (left), frequencies (middle) and decay (right).
ANOVA with post hoc tests (see Materials and methods). ∗P , 0.05, ∗∗P , 0.01 and ∗∗∗P , 0.001.
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mEJP decay kinetics are similar between all genotypes (K-S
test, P . 0.05 for each genotype; Fig. 1E), our data imply
that postsynaptic DGluRs are not affected by mutant htt ex-
pression and consistent with a presynaptic mutant htt-induced
malfunction. In agreement with previous results, we found
mean mEJP amplitudes in all UAS and Htt20Q control
larvae to be approximately 1 mV (21,24,26,27), while
Htt128Q
FL expression gave signiﬁcantly smaller mean mEJP
amplitudes of  0.7 mV (19), as did Htt93Q, conﬁrming the
suppression of quantal size relative to Htt20Q and UAS
control larvae (Fig. 1F, two-way ANOVA, htt background ×
transgene expression interaction F2,50 ¼ 4.47, P ¼ 0.016).
We also examined mEJP frequencies, which showed a margin-
ally signiﬁcant effect for transgene expression (two-way
ANOVA, F1,50 ¼ 4.94, P ¼ 0.03), but a posteriori tests did
not conﬁrm this difference in any of the three htt backgrounds,
and ANOVA did not reveal any signiﬁcant effects for decay
kinetics (Fig. 1F). As Htt93Q and Htt128Q
FL yielded similar
effects on neurotransmission, we focused on the Htt93Q
model of synaptic dysfunction in the experiments below.
Electrophysiological deﬁcits are correlated with changes in
SV size and are rescued by Rab11 overexpression
To investigate whether the observed decrease in mEJP ampli-
tudes was caused by a reduction in SV size, we undertook
ultra-structural analysis of NMJ boutons. The Drosophila
NMJ possesses two types of boutons, with 1s boutons harbour-
ing larger vesicles ( 45 nm diameter) and 1b boutons contain-
ing smaller vesicles ( 38 nm) (20). Resting synaptic activity
appears to arise primarily by SV release from 1b boutons, as
little activity is observed from 1s boutons, underscoring the
different functionality of these synapses in terms of release.
We have previously shown that the expression of a mutant
htt exon 1 fragment causes defects in local endosomal recyc-
ling mediated by the Rab11 protein (15). Therefore, Rab11
could be involved in the observed mutant htt-induced reduc-
tion in quantal size by affecting SV size. To test this, we dir-
ectly measured SV size using electron microscopy. The outer
diameters of the SV were measured in both 1s and 1b boutons
from UAS control (Fig. 2A–D) and Htt93Q larvae, as well as
larvae overexpressing both Htt93Q and Rab11. Histograms
and cumulative probability plots of the data showed a left-
shifted distribution of vesicle sizes in Htt93Q larvae (i.e.
larger relative number of smaller vesicles compared with
control) with the average vesicle size signiﬁcantly reduced
(Fig. 2E–H). This shift and the average diameter were com-
pletely restored in both 1s and 1b boutons from Htt93Q
larvae overexpressing Rab11 (Fig. 2E–H).
In addition to changes in SV size, we also observed that
NMJ boutons expressing Htt93Q showed increased numbers
of vacuoles (Supplementary Material, Fig. S2D and J), multi-
lammelar bodies (Supplementary Material, Fig. S2E) and mul-
tivesicular bodies (Supplementary Material, Fig. S2B). These
are all markers of increased lysosomal/autophagic pathways
and demonstrate that the synapse has diverted membrane ma-
terial into degradative pathways (28). Nevertheless, Htt93Q
expression did not affect the number of active zones
with SVs clustering around synaptic dense areas or T-bars,
which are indicative of active functional synapses (29) (Sup-
plementary Material, Fig. S2M). Quantifying numbers of
active zones per micrometre of membrane revealed no differ-
ence between any of the strains (Supplementary Material, Fig.
S2M). We can conclude that active synaptic regions are pre-
served in third instar larvae expressing Htt93Q, further under-
scoring that the observed electrophysiological defects are
consistent with a reduced SV size.
We postulated that the amelioration of SV size by Rab11-
overexpression could directly affect the electrophysiological
properties of mEJP and eEJP recordings in Htt93Q larvae.
To test this, we compared both eEJPs and mEJPs in Htt93Q
expressing larvae in the absence and the presence of the
Rab11 overexpression transgene. We found that the overex-
pression of Rab11 rescues the mutant htt-induced reduction
in eEJP amplitudes to levels comparable with control
Rab11-expressing larvae (F2,21 ¼ 4.46, P ¼ 0.024, Fig. 3A
and B), while mean resting membrane potentials were
similar between groups (approximately 269+5m V ,
F2,24 ¼ 0.98, n.s., Fig. 3C). The rescuing effect on eEJP ampli-
tudes was due to larger mEJP amplitudes following Rab11 ex-
pression in Htt93Q larvae (Fig. 3D; D ¼ 0.25, P ¼ 0.006).
Also, there was no signiﬁcant difference observed in mEJP
decay kinetics following Rab11 expression (Fig. 3E; D ¼
0.053, P ¼ 0.99). Comparison of mean mEJP amplitudes
(Fig. 3Fi) indicates that Rab11 overexpression completely
rescued the electrophysiological deﬁcits caused by Htt93Q ex-
pression (F2,28 ¼ 8.04, P , 0.002), but no signiﬁcant effects
were observed for either mEJP frequency or decay kinetics
(Fig. 3Fii and iii). When we compared the quantal content
(i.e. the number of SV released during a synaptic event)
among Htt93Q, Htt93Q/Rab11 and Rab11 overexpressing
larvae, we found no signiﬁcant difference (Fig. 3Fiv, F2, 16 ¼
2.84, P ¼ 0.09), suggesting that the reduced eEJP ampli-
tudes in Htt93Q-overexpressing larvae are entirely due to the
reduction in quantal size, further excluding potential effects
on the presynaptic release machinery or post-synaptic DGluR-
IIs (30).
To ensure that the protective effects of Rab11 overexpres-
sion were not due to the titration of Gal4-induced expression
from the additional UAS transgene present in these larvae,
we co-expressed Htt93Q with the control protein dsRED and
observed no alteration in the mutant htt-induced electrophysio-
logical deﬁcits (Supplementary Material, Fig. S1). Together,
these data show that Rab11 overexpression rescues the physio-
logical deﬁcit arising from the mutant htt-dependent reduction
in quantal size and evoked transmitter release. This work also
illustrates a novel interaction of mutant htt with SV formation,
ultimately leading to synaptic dysfunction, which may contrib-
ute to HD pathogenesis.
Rab11 ameliorates locomotor activity deﬁcits in mutant
htt expressing larvae
Drosophila larvae exhibit stereotypical crawling behaviour
when placed upon an agarose surface (31). Perturbations in
crawling have been used to study ﬂies with mutations in
various ion channels, including mechanosensitive channels,
as well as Drosophila models of neurodegeneration (32–35).
Larval crawling is characterized by periods of movement in
Human Molecular Genetics, 2012, Vol. 21, No. 13 2915a particular direction interrupted by turns. Thus, traces made
of larval crawling patterns allow the determination of
several metrics describing crawling behaviour, such as dis-
tance travelled or number of turns performed during a
deﬁned period of time (21,31) (Fig. 4A and B).
Having already shown that Rab11 ameliorated SV and
quantal size abnormalities, we postulated that Rab11 overex-
pression might further ameliorate any behavioural defects in
Htt93Q larvae associated with altered quantal size. To
address this question, we analysed crawling in larvae expres-
sing Htt93Q, Htt20Q or Htt93Q/Rab11, as well as appropriate
control larvae, in motor neurons using the c164-GAL4 driver
(36). Htt93Q larvae performed signiﬁcantly fewer turns than
those expressing Htt20Q or control larvae (F4,141 ¼ 8.44,
P   0, pairwise a posteriori values P ¼ 0.006, P   0,
respectively, Fig. 4C). Htt93Q larvae also exhibited a corre-
lated signiﬁcant increase in distance travelled (Fig. 4D,
F4,151 ¼ 11.7, P   0), suggesting that reducing the number
of turns permits larvae to crawl further. Normalizing distance
data by the number of turns (distance/turn) enhance the reso-
lution of these behavioural abnormalities observed in Htt93Q
larvae compared with Htt20Q larvae and other controls
(Fig. 4E, F4,151 ¼ 7.9, P   0, pairwise a posteriori values
P ¼ 0.0007 to P   0). Strikingly, Htt93Q larvae overexpres-
sing Rab11 showed a complete rescue of the larval phenotype
based on the numbers of turns, distance travelled or distance/
Figure 2. The reduced vesicle size in Htt93Q fruit ﬂy larvae is fully restored by Rab11 overexpression. (A) EM image of a 1s synaptic bouton showing the
synaptic active zone (arrows) and SVs (box) in UAS control larvae. Scale bar ¼ 500 nm. (B) 1b bouton with active zones (arrow), SVs (box) and subsynaptic
reticulum (SSR) in UAS control larvae. Scale bar ¼ 1 mm. (C) The 2.5-fold magniﬁcation of SVs (box) from (A). (D) 5-fold magniﬁcation of SVs (box) from
panel (B). Histogram and relative cumulative frequency plots of SV size for 1s (E) and 1b (F) boutons showing left shift (smaller vesicles) in Htt93Q larvae
compared with UAS control (numbers indicate counted vesicles per genotype). Rab11 overexpression restores vesicle size. (G and H) The average vesicle size
for both boutons and the condition indicated. The mean vesicle size in Htt93Q larvae is smaller compared with UAS control. Vesicle size is restored for both 1s
and 1b boutons when Rab11 is expressed. ANOVA with post hoc tests ∗P , 0.05 and ∗∗∗P , 0.0001.
2916 Human Molecular Genetics, 2012, Vol. 21, No. 13Human Molecular Genetics, 2012, Vol. 21, No. 13 2917turn (P ¼ 0.0002 to P   0, respectively). These results com-
plement our electrophysiological observations and indicate
that the restoration of synaptic transmission by Rab11 overex-
pression recovers the disrupted behavioural readouts of larvae
expressing mutant htt.
DISCUSSION
The majority of research on HD and other neurodegenerative
disorders has focused on elucidating the mechanisms under-
lying neurodegeneration and identifying therapeutic interven-
tions that prevent cell death. However, it is clear that the
neuronal and synaptic dysfunction occurring prior to neuronal
death plays an important role in the pathogenesis of the
disease (7). Here, we ﬁnd that mutant htt causes a synaptic
dysfunction at the larval Drosophila NMJ by decreasing the
SV size, and ultimately impairing synaptic transmission. Res-
toration of SV volume by the overexpression of Rab11 as
shown by an electron microscopy is sufﬁcient to completely
restore synaptic function at the electrophysiological level,
thereby implicating Rab11 in these processes. The observed
synaptic deﬁcits correlate with abnormal larval behaviour
which was also ameliorated by Rab11 overexpression. These
observations support a model in which mutant htt alters SV
size, leading to synaptic and behavioural dysfunction that
Rab11 overexpression is able to reverse (Fig. 5).
Our observations complement previous work in HD patient
ﬁbroblasts showing that mutant htt inhibits the activation of
Rab11 (the guanosine triphosphate (GTP)-bound form) and
that the disruption of this process leads to the defective forma-
tion of vesicles from recycling endosomes (13). Supporting
this work, we previously found that levels of Rab11 were sig-
niﬁcantly decreased and endocytic recycling was impaired in a
cell and mouse model of HD—further connecting alterations
in the Rab11 function with impaired vesicle formation (15).
SV size may also be altered by aberrant gain-of-function inter-
actions of mutant htt with proteins such as the SV chaperone
CSP and PACSIN1, which regulates vesicle recovery (37).
Wild-type htt function is required for clathrin-mediated endo-
cytosis during SV recovery (7), and so it is clear that several
factors may contribute to this neuronal process in HD path-
ology. Indeed, presynaptic endocytotic dysregulation involv-
ing htt-interacting protein 1 (HIP1), an accessory protein for
clathrin-mediated endocytosis, has been implicated in HD
(38). This clathrin-dependent pathway of endocytosis might
be relevant in explaining our ﬁndings of compromised synap-
tic transmission as clathrin-mediated SV recycling at
Drosophila NMJs is fundamental for the maintenance of syn-
aptic transmission (Fig. 5)( 39). Taken together, our data point
towards the mutant htt-mediated dysregulation of endocytotic
pathways leading to a reduction in SV size, with Rab11 pro-
viding a mechanism to overcome these detrimental effects.
The mechanism by which Rab11 restores SV size is unclear.
Previous work has indicated that wild-type htt functions in a
protein complex which acts as a guanine exchange factor for
Rab11 (40). Mutant htt may thus block the activation of
Rab11 to its GTP-bound form by the inhibition of normal
htt function in this process (13), leading to defective vesicle
formation. Thus, it is possible that the overexpression of
Rab11 in our system circumvents this block in activation, re-
storing SV size and rescuing the consequent electrophysio-
logical and locomotor deﬁcits.
Interestingly, two previous studies have found that the ex-
pression of a mutant htt exon 1 fragment at the murine NMJ
(41) or full-length htt (Htt128Q
FL) at the NMJ in Drosophila
larvae (19) enhances neurotransmission, seemingly contradict-
ing our ﬁndings. However, the Htt128Q
FL-induced enhance-
ment of release probability at the Drosophila larvae NMJ in
this other study was observed under low, non-physiological
extracellular Ca
2+ levels (0.25 and 0.6 mM), which limits the
ability to extrapolate these results to physiological conditions.
Furthermore, alterations in cytosolic Ca
2+ levels have also
been implicated in the pathology of HD model mice, with
reduced Ca
2+ inﬂux affecting neurotransmitter release (42).
For these reasons, we focused our studies on observations at
physiological Ca
2+ (1.5 mM) inﬂux levels. It is important to
underscore that we observed reduced neurotransmission at
the NMJ with both an htt exon 1 fragment and a full-length
htt construct, suggesting a general phenomenon due to
mutant htt expression. Furthermore, as Rab11 overexpression
both reverses this phenotype and reduced SV size, our data
are best explained by a mutant htt-mediated reduction in
quantal sizes due to a decreased SV size, without changes to
transmitter release probability.
We also observed the appearance of vacuoles, multivesicu-
lar bodies and multilammelar bodies in HD ﬂy larvae, indicat-
ing increased lysosomal/autophagic activity in these cells and
the diversion of membrane material into degradative orga-
nelles. However, while Rab11 overexpression signiﬁcantly
increased SV size and restored the electrophysiological prop-
erties of the synapse, it had no effect on the appearance of
vacuoles, multivesicular bodies and multilammelar bodies.
Furthermore, we did not observe any change in the number
of synaptic active zones in these animals. Taken together,
these data suggest that impairment in SV recycling could rep-
resent an early stage in the pathology of HD which precedes
synaptic loss.
Our previous work found that the loss of dendritic spines in
hippocampal neurons is correlated with proximity of the
spines to mutant htt aggregates (15) and that Rab11 restores
dendritic spine density—suggesting that the aggregation
Figure 3. Rab11 expression rescues the mutant htt-induced reduction in evoked transmission and quantal size. (A) eEJP recordings from larvae expressing
Htt93Q, Htt93Q plus Rab11 or Rab11 alone. (B) Mean eEJP amplitudes are rescued by Rab11 expression. (C) Mean resting membrane potentials are
similar between all genotypes. (D) Top, mEJP sample trace. Middle, relative cumulative frequency histogram for mEJP amplitudes: Rab11 expression
(green, Htt93Q/Rab11) rescues the htt-induced reduction (grey, Htt93Q as in Figure 1D) in mEJP amplitudes. Bottom, mEJP amplitude histogram shows the
right shift of amplitude distribution following Rab11 expression. (E) Top, mEJP sample trace. Middle, relative cumulative histogram for mEJP decay: there
is no difference in decay distributions between genotypes. Bottom, mEJP decay histogram. UAS control larvae carry both the UASHtt93Q and the
UASRab11 insertions (genotype w; UASRab11/+; UASHtt93Q/+). (F) Summary graphs for mEJP amplitudes (i), frequencies (ii), decay (iii) and quantal
content (iv). Data denote the mean+SEM with n number of larvae indicated within each bar. ANOVA with post hoc tests. ∗P , 0.05.
2918 Human Molecular Genetics, 2012, Vol. 21, No. 13state of mutant htt could be central to synaptic phenotypes. In
the current study, we ﬁnd that the expression of either an exon
1 fragment (Htt93Q) or full-length mutant htt construct
(Htt128
FL) causes a reduction in quantal size in the NMJ of
Drosophila larvae. While third instar larvae expressing
Htt93Q exhibit mutant htt containing aggregates (43),
Htt128
FL larvae do not form mutant htt aggregates (19), sug-
gesting that the observed synaptic dysfunction is independent
of insoluble aggregates or visible inclusions. These data do not
exclude the possibility that soluble oligomers of mutant htt—
thought to be an important determinant in the cellular toxicity
observed in HD (44)—are responsible for the observed effects
on dendritic spines. Recent work in mammalian cells has
found that mutant htt forms an invariant pool of oligomers
that is independent of insoluble aggregate load (45), suggest-
ing that localized differences in oligomer concentration
within a cell may be critical. Indeed, mutant htt oligomers
are enriched proximal to insoluble ﬁbrils in both mammalian
cells and HD patient samples (46); thus, dendritic spines
close to aggregates may be subjected to higher concentrations
of oligomers. Interestingly, mutant htt also appears to block
axonal transport in neurons of Drosophila larvae, which may
play an early role in synaptic dysfunction (43,47,48). Discern-
ing the mechanism(s) by which mutant htt alters synaptic phe-
notypes will be a critical area for future investigations.
Our work sheds light on the importance of Rab11 in early
synaptic dysfunction in HD. These ﬁndings resonate with
recent studies in HD (12–15,40) and may also impact on re-
search in other neurodegenerative disorders, such as
Alzheimer’s disease and Parkinson’s disease. Indeed, Rab11
activity has been found to modulate the recycling of extracel-
lular a-synuclein (49), interact speciﬁcally with presenilin 1
Figure 5. Model of impaired neurotransmission caused by mutant htt. Mutant htt leads to reduced SV size via reduced Rab11 function and altered interactions
with HIP1, causing reduced neurotransmitter release, and synaptic dysfunction. Overexpression of Rab11 reverses these defects.
Figure 4. DefectivelarvalcrawlingbehaviourisrescuedbyRab11.(A)Representativeexampleofcrawlingtracesproducedbycontrollarva(w;c164GAL4/+, +).
(B) Trace of larva overexpressingHtt93Qin motorneurons with the c164 driver (w; c164GAL4/+; UASHtt93Q/+). (C) Mean turns,(D) distanceand (E) distance/
turns in larvae overexpressing Htt93Q, Htt93Q/Rab11, Htt20Q or Gal4 and Rab11 controls driven in motor neurons by the c164 promoter. Data are mean+SEM.
ANOVA with post hoc tests. ∗P , 0.05, ∗∗P , 0.01 and ∗∗∗P , 0.001.
Human Molecular Genetics, 2012, Vol. 21, No. 13 2919(50) and play a role in oestrogen-regulated trafﬁcking of
b-amyloid in the late secretory pathway (51). It is clear that
future mechanistic studies should continue to explore the
role of Rab11 activity in HD pathology, and that these ﬁndings
should be exploited for potential therapeutic strategies which
increase Rab11 activity (52).
MATERIALS AND METHODS
Fly stocks
Flies were raised on maize media, in LD12:12 at 258C. The
elav-GAL4 [c155] driver and the w; UASRab11-GFP; +
(8506) stocks were obtained from the Bloomington Stock
Center (Indiana). The c164-GAL4 driver (36) and the full-
length Htt128Q yw; UASFLHtt128Q; + (M36E2) were
kindly donated by Juan Botas (Baylor College of Medicine).
The w; +; UASHttQ93 exon1 and w; UASHtt20Q exon1
ﬂies were a gift from J. Lawrence Marsh and Leslie Thompson
(University of California, Irvine).
Electrophysiology
eEJP and mEJP were recorded with sharp electrodes from
muscle 6 (abdominal segments A2/A3, Fig. 1A) of wandering
third instar larvae in the current-clamp mode (MultiClamp
700B) in haemolymph-like (HL-3) solution containing 1.5 or
0.6 mM Ca
2+ (indicated) as described previously (21). Record-
ing electrodes (10–20 MV) were ﬁlled with 3 M KCl. mEJP
recordings were performed in the presence of 1 mM tetrodo-
toxin. All eEJP/mEJPs were recorded from muscles with
resting potentials more negative than 260 mV at 228C as dif-
ferences in recording temperature cause changes in glutamate
receptor kinetics and amplitudes (53). All larval rearing tem-
peratures were 258C as temperature ﬂuctuations result in
changes of NMJ morphology and evoked responses (54).
mEJPs and eEJPs were low-pass ﬁltered at 1 kHz and digitized
using a Digidata1321A. Data were collected from averaged 50
eEJPs and 120 s of mEJP recordings per muscle using pClamp
9.2 software.
Electron microscopy
Third instar larvae were ‘ﬁlleted’ and ﬁxed in freshly prepared
cacodylate/paraformaldehyde for 20 min at room temperature.
Samples were then ﬁxed in 2% glutaraldehyde in 0.1 M
sodium cacodylate buffer (pH 7.4) at 48C overnight and post-
ﬁxed with 1% osmium tetroxide/1% potassium ferrocyanide
for 1 h at room temperature. After ﬁxation, cells were
stained en bloc with 5% aqueous uranyl acetate overnight at
room temperature, dehydrated and embedded in Taab epoxy
resin (Taab Laboratories Equipment Ltd, Aldermaston, UK).
Semi-thick sections were collected onto glass slides and
stained with Toluidine blue to identify areas that contained
synaptic regions. Thin sections, of  90 nm thickness, were
cut from each sample using a Reichert Ultracut S or EMU
C7 ultramicrotome, collected on copper mesh grids and
counter stained with 2% uranyl acetate and Reynold’s lead
citrate. Sections were observed using a JEOL 1220 or JEOL
1400 transmission electron microscope, using an accelerating
voltage of 80 kV. Digital images were recorded using a SIS
Megaview III Digital Camera with iTEM Software. SV mea-
surements were made using ImageJ software (http://rsbweb.
nih.gov/ij/index.html). A total of  600 SVs were measured
in 11–14 boutons from three animals per genotype.
Larval crawling assay
Prior to commencing crawling assays, Drosophila third instar
larvae were staged by propagating on maize food dyed with
0.05% Bromophenol blue, as described previously (55). As
the larvae wandered, they stopped feeding and the blue dye
gradually cleared from their intestines (56). Three types of
wandering larvae could therefore be distinguished: those
with dark blue guts (the youngest that will pupariate in 12–
24 h), those with light blue guts (intermediate, will pupariate
in 5–12 h) and those with an almost completely clear gut
(the oldest that will pupariate in 1–6 h). Only younger, deep
blue coloured, third instar larvae were used for our crawling
assays. Each larva was brieﬂy washed in distilled water and
then placed in the middle of a 145-mm plate coated with
0.8% agarose. The larva was allowed to crawl for 2 min and
the distance covered by it was manually drawn on transparent
paper placed on the lid of the plate. The number of turns per-
formed by each larva was counted manually. The distance
crawled by each larva was calculated by scanning each
larval trace and measuring its track length with Image J soft-
ware (http://rsbweb.nih.gov/ij/). For each genotype, the crawl-
ing behaviour of 25–50 larvae was analysed.
The motoneuronal genotypes assayed were c164Htt93Q
(w/w; c164GAL4/+;U A S H t t 9 3 Q / +), c164Htt93QRab11
(w/w; c164GAL4/UASRab11; UASHtt93Q/+), c164Htt20Q (w/w;
c164GAL4/+; UASHtt20Q/+), c164GAL4 (w/w; c164GAL4/+;
+/+)a n dc164Rab11 (w/w; c164GAL4/UASRab11/+; +/+).
The number of turns was calculated by adding 1 to the actual
number of turns performed by the larva, and then calculating the
log10 of such number [log10(n + 1)]. This log transformation was
p e r f o r m e dt oo b t a i nan o r m a l i zed distribution of the data.
Statistics
Data are expressed as mean+SEM, where n indicates the
number of muscles/larvae examined. Statistical analyses
were carried out using ANOVA where applicable with the
Duncan and Newman–Keuls a posteriori tests. Cumulative
frequency distributions were compared using the K-S test.
For the behavioural assays, statistical analyses were performed
using ANOVA with post hoc tests.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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